Assignee
ASTRAZENECA
SE·12 granted patents·9 pending applications·239 citations·filing 2000–2011
Top patents by PatentIndex Score
21 records- 0195US6710052B2Pyrimidine compoundsASTRAZENECA·Filed 2001·Granted Mar 23, 2004·106 cites·14 claims
- 0294US7067532B2Substituted quinolines as antitumor agentsASTRAZENECA·Filed 2001·Granted Jun 27, 2006·42 cites·8 claims
- 0389US6784171B2Process for the production of tert-butyl (E)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4R,6S)-2, 2-dimethyl[1, 3]dioxan-4-yl)acetateASTRAZENECA·Filed 2003·Granted Aug 31, 2004·42 cites·11 claims
- 0483US8371449B2PackageASTRAZENECA·Filed 2011·Granted Feb 12, 2013·10 cites·18 claims
- 0583US7709479B1Quinazoline derivatives and their use as pharmaceuticalsASTRAZENECA·Filed 2000·Granted May 4, 2010·19 cites·3 claims
- 0679US7645751B2Mandelic acid derivatives and their use as thrombin inhibitorsASTRAZENECA·Filed 2007·Granted Jan 12, 2010·2 cites·17 claims
- 0770US7622482B2Chemical compoundsASTRAZENECA·Filed 2006·Granted Nov 24, 2009·1 cites·13 claims
- 0870US7115615B2Quinazoline derivativesASTRAZENECA·Filed 2001·Granted Oct 3, 2006·6 cites·18 claims
- 0969US7897778B2Benzamide compoundsASTRAZENECA·Filed 2005·Granted Mar 1, 2011·1 cites·14 claims
- 1069US6723723B1Heterocyclic derivatives as inhibitors of factor XaASTRAZENECA·Filed 2000·Granted Apr 20, 2004·5 cites·13 claims
- 1165US7579342B2Pteridine compounds for the treatment of psoriasisASTRAZENECA·Filed 2004·Granted Aug 25, 2009·3 cites·6 claims
- 1260US8038006B2Blister-type packaging for inhalersASTRAZENECA·Filed 2008·Granted Oct 18, 2011·2 cites·11 claims
- 1360US2005161440A1Metallic implant and process for treating a metallic implantASTRAZENECA·Filed 2005·Application pending·0 cites
- 1453US2011053923A1Chemical compounds 610ASTRAZENECA·Filed 2009·Application pending·0 cites
- 1547US2010216791A1Pyridinylquinazolinamine derivatives and their use as b-raf inhibitorsASTRAZENECA·Filed 2007·Application pending·0 cites
- 1645US2007142386A1New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1ASTRAZENECA·Filed 2004·Application pending·0 cites
- 1744US2009270390A1Pyrimidine derivativesASTRAZENECA·Filed 2007·Application pending·0 cites
- 1844US2010022534A12-benzimidazolyl-6-morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 1943US2008194606A1Pyrazolyl-Amino-Substituted Pyrimidines and Their Use in the Treatment of CancerASTRAZENECA·Filed 2006·Application pending·0 cites
- 2041US2009233926A12-benzimidazolyl-6-morpholino-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 2137US2009105484A1Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agentsASTRAZENECA·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →